Emissions of remedies

Full list of emissions of pharmaceuticals and curative plants: Actovegin, Allergy treatment, Arbidol, Deltaran, Dilacor, Esentiale, Fosamax, Liver treatment, Noni, Prednisolone, Preductal, Samprost, Soursop, Ursosan, Weight loss complex.

Number of downloads: 1377
Active ingredient - Prednisolone

Brand names: Bubbli-Pred, Flo-Pred, Hydeltrasol, Key-Pred SP, Millipred, Orapred, Orapred ODT, Pediapred, Pred-Ject-50, Predacort 50, Predalone 50, Predate-50, Veripred 20, Prelone, Hydeltra-T.B.A., Key-Pred, Cotolone, Depo-Predate (obsolete), Predicort-50, Predaject-50, Medicort, Predicort RP, Pri-Cortin 50, Predcor, Millipred DP, AsmalPred Plus.

Indications and usage:

- Endocrine disorders. Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). Congenital adrenal hyperplasia, Nonsuppurative thyroiditis, Hypercalcemia associated with cancer - Rheumatic disorders. As adjunctive therapy for short-term administration (for patients experiencing acute episodes or exacerbation) in: Psoriatic arthritis, Rheumatoid arthritis including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy), Ankylosing spondylitis, Acute and subacute bursitis, Acute nonspecific tenosynovitis, Acute gouty arthritis, Post-traumatic osteoarthritis, Synovitis of osteoarthritis, Epicondylitis
- Collagen diseases. During an exacerbation or as maintenance therapy in selected cases of: Systemic lupus erythematosus, Acute rheumatic carditis, Systemic dermatomyositis (polymyositis)
- Dermatologic diseases: Pemphigus, Bullous dermatitis herpetiformis, Severe erythema multiforme (Stevens-Johnson syndrome), Exfoliative dermatitis, Mycosis fungoides, Severe psoriasis, Severe seborrheic dermatitis
- Allergic states. Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment: Seasonal or perennial allergic rhinitis, Serum sickness, Bronchial asthma, Contact dermatitis, Atopic dermatitis, Drug hypersensitivity reactions
- Ophthalmic diseases. Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: Allergic conjunctivitis, Keratitis, Allergic corneal marginal ulcers, Herpes zoster ophthalmicus, Iritis and iridocyclitis, Chorioretinitis, Anterior segment inflammation, Diffuse posterior uveitis and choroiditis, Optic neuritis, Sympathetic ophthalmia.
- Respiratory diseases. Symptomatic sarcoidosis, Loeffler's syndrome not manageable by other means, Berylliosis, Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, Aspiration pneumonitis.
- Hematologic disorders. Idiopathic thrombocytopenic purpura in adults, Secondary thrombocytopenia in adults, Acquired (autoimmune) hemolytic anemia, Erythroblastopenia (RBC anemia), Congenital (erythroid) hypoplastic anemia
- Neoplastic diseases. For palliative management of: Leukemias and lymphomas in adults, Acute leukemia of childhood
- Edematous states. To induce a diuresis or remission of proteinuria in the nephritic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus.
- Gastrointestinal diseases. To tide the patient over a critical period of the disease in: Ulcerative colitis, Regional enteritis
- Nervous system. Acute exacerbations of multiple sclerosis
- Miscellaneous. Tuberculous meningitis with sub-arachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy. Trichinosis with neurologic or myocardial involvement

New pharmaceutical form

Tablets, injections, infusions cream, gel, ointment




Not available at the US and European markets

Side effects

None, as there is no chemical component

Side effects

  • Fluid and Electrolyte Disturbances
  • Sodium retention. Fluid retention. Congestive heart failure in susceptible patients. Potassium loss. Hypokalemic alkalosis. Hypertension.
  • Musculoskeletal
  • Muscle weakness. Steroid myopathy. Loss of muscle mass. Osteoporosis. Vertebral compression fractures. Aseptic necrosis of femoral and humeral heads. Pathologic fracture of long bones.
  • Gastrointestinal
  • Peptic ulcer with possible perforation and hemorrhage. Pancreatitis. Abdominal distention. Ulcerative esophagitis.
  • Dermatologic
  • Impaired wound healing. Thin fragile skin. Petechiae and ecchymoses. Facial erythema. Increased sweating. May suppress reactions to skin tests.
  • Neurological
  • Convulsions. Increased intracranial pressure with papilledema (pseudotumor cerebri) usually after treatment. Vertigo. Headache.
  • Endocrine
  • Menstrual irregularities. Development of Cushingoid state. Suppression of growth in children. Secondary adrenocortical and pituitary unresponsiveness, particularly in times of stress, as in trauma, surgery, or illness. Decreased carbohydrate tolerance. Manifestations of latent diabetes mellitus. Increased requirements for insulin or oral hypoglycemic agents in diabetics.
  • Ophthalmic
  • Posterior subcapsular cataracts. Increased intraocular pressure. Glaucoma. Exophthalmos.
  • Metabolic
  • Negative nitrogen balance due to protein catabolism.
  • Oral solution/syrup, tablets, injections


None, as there is no chemical component


  • Prednisolone is contraindicated in systemic fungal infections and known hypersensitivity peptic ulcer, acute psychosis, cushing's syndrome, herpes simplex keratitis, CHF and in lactation.

  • Emission

    The essence of the “Emission” project is the possibility to transmit emission (properties) of organic and inorganic substances and biological objects remotely via communication lines using Internet addressing system.

  • Artificial Blood Substitute

    Authors of the invention: Ph.D. Biology, Candidate of Chemical Sciences, Kuznetsova Irina and Ph.D. Medicine Evgeny Maevsky. AT300 was developed on the basis of the Russian Scientific-Research Institute of Hematology and Transfusion Medicine, St. Petersburg.

  • Cancer treatment

    Dissymetric therapy (anisotropizing) tinctorial therapy (DST) – is an innovative method of oncological diseases treatment. It is based on the theory of Professor Kutushov about the causes of cancer and it's development.